financetom
Business
financetom
/
Business
/
Novartis weighs deal for biotech Avidity Biosciences, FT reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novartis weighs deal for biotech Avidity Biosciences, FT reports
Aug 6, 2025 8:56 AM

(Corrects typo in paragraph 1)

(Reuters) -Swiss drugmaker Novartis has approached U.S. biotech Avidity Biosciences for a potential takeover offer, the Financial Times reported, citing people familiar with the matter

(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Arun Koyyur)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Taseko Mines Says Environmental Assessment Process for the Yellowhead Copper Project Underway
Taseko Mines Says Environmental Assessment Process for the Yellowhead Copper Project Underway
Jul 8, 2025
12:10 PM EDT, 07/08/2025 (MT Newswires) -- Taseko Mines ( TGB ) (TKO.TO, TKO) on Tuesday said the Initial Project Description for its 100% owned Yellowhead Copper Project has been filed and accepted by the British Columbia Environmental Assessment Office and Impact Assessment Agency of Canada. The company said the acceptance formally begins the environmental assessment process. The project, which...
Update: Recursion, Rallybio Shares Rise After Deal on Joint Hypophosphatasia Candidate
Update: Recursion, Rallybio Shares Rise After Deal on Joint Hypophosphatasia Candidate
Jul 8, 2025
12:07 PM EDT, 07/08/2025 (MT Newswires) -- (Updates with stock moves in the headline and the first paragraph.) Recursion Pharmaceuticals ( RXRX ) shares rose nearly 12% and Rallybio ( RLYB ) was up 37% in recent Tuesday trading after Recursion said it has acquired Rallybio's ( RLYB ) full interest in their joint program of the therapy REV102, which...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Judge orders CVS' Omnicare unit to pay $949 million over invalid prescriptions
Judge orders CVS' Omnicare unit to pay $949 million over invalid prescriptions
Jul 8, 2025
NEW YORK, July 8 (Reuters) - A federal judge ordered CVS Health's ( CVS ) Omnicare unit to pay $948.8 million in penalties and damages, in a whistleblower lawsuit claiming it fraudulently billed the U.S. government for invalid drug prescriptions. In a Monday evening order, U.S. District Judge Colleen McMahon in Manhattan imposed a $542-million penalty for filing 3,342,032 false...
Copyright 2023-2026 - www.financetom.com All Rights Reserved